BMS agrees $1.7bn immuno-oncology collaboration
Monday, October 19, 2015 - 06:50
in Health & Medicine
Deal strengthens cancer antibody alliance with Five Prime Therapeutics
Deal strengthens cancer antibody alliance with Five Prime Therapeutics